131 related articles for article (PubMed ID: 38054361)
1. Transporters involved in adult rat cortical astrocyte dopamine uptake: Kinetics, expression and pharmacological modulation.
Sočan V; Dolinar K; Kržan M
Eur J Neurosci; 2024 Mar; 59(6):1296-1310. PubMed ID: 38054361
[TBL] [Abstract][Full Text] [Related]
2. Kinetic Properties and Pharmacological Modulation of High- and Low-Affinity Dopamine Transport in Striatal Astrocytes of Adult Rats.
Sočan V; Dolinar K; Kržan M
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791173
[TBL] [Abstract][Full Text] [Related]
3. Cortical and Striatal Astrocytes of Neonatal Rats Display Distinct Molecular and Pharmacological Characteristics of Dopamine Uptake.
Sočan V; Dolinar K; Kržan M
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255983
[TBL] [Abstract][Full Text] [Related]
4. Astroglial dopamine transport is mediated by norepinephrine transporter.
Takeda H; Inazu M; Matsumiya T
Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):620-3. PubMed ID: 12444505
[TBL] [Abstract][Full Text] [Related]
5. Functional expression of the norepinephrine transporter in cultured rat astrocytes.
Inazu M; Takeda H; Matsumiya T
J Neurochem; 2003 Jan; 84(1):136-44. PubMed ID: 12485410
[TBL] [Abstract][Full Text] [Related]
6. Cell-type-specific expression of catecholamine transporters in the rat brain.
Lorang D; Amara SG; Simerly RB
J Neurosci; 1994 Aug; 14(8):4903-14. PubMed ID: 8046459
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization and visualization of the glial serotonin transporter.
Inazu M; Takeda H; Ikoshi H; Sugisawa M; Uchida Y; Matsumiya T
Neurochem Int; 2001 Jul; 39(1):39-49. PubMed ID: 11311448
[TBL] [Abstract][Full Text] [Related]
8. Predominant role of plasma membrane monoamine transporters in monoamine transport in 1321N1, a human astrocytoma-derived cell line.
Naganuma F; Yoshikawa T; Nakamura T; Iida T; Harada R; Mohsen AS; Miura Y; Yanai K
J Neurochem; 2014 May; 129(4):591-601. PubMed ID: 24471494
[TBL] [Abstract][Full Text] [Related]
9. Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats.
Conti MM; Meadows SM; Melikhov-Sosin M; Lindenbach D; Hallmark J; Werner DF; Bishop C
Neuropharmacology; 2016 Nov; 110(Pt A):125-134. PubMed ID: 27452719
[TBL] [Abstract][Full Text] [Related]
10. Clobenpropit, a histamine H
Mena-Avila E; Márquez-Gómez R; Aquino-Miranda G; Nieto-Alamilla G; Arias-Montaño JA
Pharmacol Rep; 2018 Feb; 70(1):146-155. PubMed ID: 29414147
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of dopamine transport in cultured rat astrocytes.
Inazu M; Kubota N; Takeda H; Zhang J; Kiuchi Y; Oguchi K; Matsumiya T
Life Sci; 1999; 64(24):2239-45. PubMed ID: 10374914
[TBL] [Abstract][Full Text] [Related]
12. Dopamine transporter loss in 6-OHDA Parkinson's model is unmet by parallel reduction in dopamine uptake.
Chotibut T; Apple DM; Jefferis R; Salvatore MF
PLoS One; 2012; 7(12):e52322. PubMed ID: 23300642
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters.
Dutta AK; Santra S; Sharma H; Voshavar C; Xu L; Mabrouk O; Antonio T; Reith ME
PLoS One; 2014; 9(11):e113420. PubMed ID: 25427177
[TBL] [Abstract][Full Text] [Related]
14. α-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter: A pharmacological characterization of interactions between pyrrolidinopropiophenones and high and low affinity monoamine transporters.
Maier J; Rauter L; Rudin D; Niello M; Holy M; Schmid D; Wilson J; Blough BE; Gannon BM; Murnane KS; Sitte HH
Neuropharmacology; 2021 Jun; 190():108570. PubMed ID: 33864800
[TBL] [Abstract][Full Text] [Related]
15. A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters.
Robertson SD; Matthies HJ; Galli A
Mol Neurobiol; 2009 Apr; 39(2):73-80. PubMed ID: 19199083
[TBL] [Abstract][Full Text] [Related]
16. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
Verrico CD; Miller GM; Madras BK
Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
[TBL] [Abstract][Full Text] [Related]
17. Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes.
Xie Z; Westmoreland SV; Miller GM
J Pharmacol Exp Ther; 2008 May; 325(2):629-40. PubMed ID: 18310473
[TBL] [Abstract][Full Text] [Related]
18. Catecholamine uptake, storage, and regulated release by ovarian granulosa cells.
Greiner M; Paredes A; Rey-Ares V; Saller S; Mayerhofer A; Lara HE
Endocrinology; 2008 Oct; 149(10):4988-96. PubMed ID: 18566131
[TBL] [Abstract][Full Text] [Related]
19. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
Pifl C; Reither H; Hornykiewicz O
Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
[TBL] [Abstract][Full Text] [Related]
20. Further characterisation of the interaction of haloperidol metabolites with neurotransmitter transporters in rat neuronal cultures and in transfected COS-7 cells.
Siebert GA; Pond SM; Bryan-Lluka LJ
Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):255-64. PubMed ID: 10731037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
